View all trials
Are you a member? Sign in above to view additional information
  • Study title
    Pilot Study of Nivolumab in Pediatric Patients with Hypermutant Cancers
  • Protocol ID
    OZM-075
  • Disease
    Disease Type Disease Subtype
    All Tumour Types All
  • Eligibility criteria
  • Study Status
    Open
  • Location(s)
    Queensland Children's Hospital
    • Centre Study Status:
      Open
    • Notes:
  • Phase
    Pilot
  • Study type
    Treatment
  • Diagnosis stage
    Relapse/refractory
  • Study open date
    06/12/2019
  • Study close date
    N/A
  • Study chair
    David Ziegler
  • Sponsor
    Australian and New Zealand Children's Haematology Oncology Group
Back to search results